Pomalidomide is a derivative of thalidomide marketed by Celgene. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide was approved in February 2013, by the US Food and Drug Administration as a treatment for relapsed and refractory multiple myeloma.
Share This
Be the first to review “Buy IMNOVID 4 MG 21 CAP. Pomalidomide”
No more offers for this product!
General Inquiries
There are no inquiries yet.
There are no reviews yet.